Labshake search
Citations for R&D Systems :
51 - 100 of 10000+ citations for 7 Benzyl 4 chloro 5 6 7 8 tetrahydropyrido 3 4 d pyrimidin 2 amine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... IL-7 and stem cell factor (all from R&D systems) in α-MEM (Gibco ...
-
bioRxiv - Immunology 2022Quote: ... and IL-7 (50 ng/ml, R&D systems, #407-ML). After 2 to 4 weeks ...
-
bioRxiv - Biochemistry 2023Quote: ... His10-FLAG-BRD4 (0.2 μL, 7 μM, R&D Systems, SP600100), ubiquitin (10 μL ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human interleukin 4 (IL-4) (R&D Systems), Alpha MEM with nucleosides (StemCell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... Naïve CD8+ T cells were cultured in R10 media containing 5 ng/mL IL-7 (R&D systems). C57BL/6 CD8+ T cells were purified using the EasySep Mouse CD8 T Cell Isolation Kit (Stemcell technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged by dissociation in 0.5 mM EDTA every 3-4 days and resuspended in Essential 8 Medium supplemented with Y-27632 dihydrochloride (10 μM; Cat.#1254; R&D Systems). For CRISPR-Cas9 editing ...
-
bioRxiv - Developmental Biology 2022Quote: ... 0.03 to 3 μg/well of the soluble mouse or human HA-tagged recombinant fibulin 7 (R&D Systems) in 2% dry milk/TBS and 2 mM CaCl2 were added to the wells and incubated for 3 hours ...
-
bioRxiv - Immunology 2019Quote: ... and 5 ng/ml IL-4 (R&D Systems, #404-ML-010). After 24-72 hr the cells were resuspended by pipetting ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Cell Biology 2023Quote: ... 2ng/mL rhIL-7 and 0.4ng/mL rhIL-15 (R&D Systems). T cells were transduced 24 hours post-activation with lentivirus encoding an anti-EGFR CAR with 41bb/CD3ζ ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant Biotin-tagged K48-linked poly-ubiquitin chains (2-7) and K48-linked poly-ubiquitin chains (2-16) were purchased from R&D Systems and Enzo Life Science ...
-
bioRxiv - Immunology 2021Quote: ... mice were injected subcutaneously with IL-4 complex (IL-4c) comprised of rmIL-4 (2 μg, R&D systems) combined with anti-IL-4 antibody 10 μg ...
-
bioRxiv - Microbiology 2023Quote: ... Mice were sacrificed 24h post-infection and n=7 were analysed for bacterial load and IL-6 and KC using ELISA (R&D systems). A further n=3 animals were analysed using histology ...
-
bioRxiv - Immunology 2021Quote: ... and interleukin 4 (IL-4; 500 U/mL; R&D Systems). GM-CSF and IL-4 were replenished on day 2 and 4 ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Immunology 2021Quote: ... magnetically isolated T cells were resuspended in the complete medium and were seeded in a 10-cm petri dish or T-75 flask at 1–2×106 cells/cm2 and cultured in the presence of 20 ng/mL recombinant mouse interleukin-7 (rmIL-7; 402-ML-020/CF, R&D Systems, Minneapolis, MN) for 24 hr at 37°C in a humidified 5% CO2 atmosphere.
-
bioRxiv - Bioengineering 2023Quote: ... 8 μM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/ml fibroblast growth factor 9 (FGF9 ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse Integrin alpha 7 Alexa Fluor 750-conjugated Antibody (FAB3518S, R&D Systems), APC anti-mouse CD45 Antibody (103111 ...
-
bioRxiv - Bioengineering 2023Quote: ... induction of intermediate mesoderm began using 7 µM CHIR99021 (R&D Systems, 4423), a Wnt agonist ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-4-HNE (R&D Systems) was used with an AF647 secondary antibody (Invitrogen ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed at day 7 and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 250 U/ml IFN-α (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... Interleukin 4 (IL-4) and Interferon Gamma (IFNy) from R&D Systems/Bio-Techne (R&D Systems/Bio-Techne ...
-
bioRxiv - Cell Biology 2022Quote: ... 5 μg/ml heparin and 50 ng/ml BMP-4 (#5020BP, R&D System). Seventy-two hours after induction ...
-
bioRxiv - Immunology 2022Quote: ... IL-4 (50 ng/ml) and TGF-β (5 ng/ml) (R&D Systems) for TH9 cells ...
-
bioRxiv - Cancer Biology 2024Quote: ... Secondary antibody was added for ULBP 1 and 2/5/6 only (R&D Systems). Cells were then washed and fixed in 4% paraformaldehyde ...
-
bioRxiv - Developmental Biology 2022Quote: ... Mesoderm lineage explants were generated using recombinant BMP4/7 heterodimer protein (R&D Systems) at a final concentration of 20g/mL in 1xMMR supplemented with 0.1% BSA ...
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Immunology 2023Quote: ... in media containing 10 ng/ml IL-7 (BT-007-010; R&D Systems) at 37°C in 5% CO2 and after 3.5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... offspring at postnatal day 3 to 6 received 7 intraperitoneal injections with either PBS (controls) or 75 ng of carrier free recombinant mouse interleukin-6 (rmIL6, R&D Systems, Minneapolis MN).
-
bioRxiv - Developmental Biology 2022Quote: ... containing 25 ng/ml bone morphogenetic protein-4 (BMP-4, R&D Systems) and 1 μM all-trans Retinoid Acid (RA ...
-
bioRxiv - Cell Biology 2022Quote: ... and 10 ng/mL bone morphogenetic protein 4 (BMP-4) (R&D System) for five days ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Developmental Biology 2021Quote: ... anti-Oct3/4 (MAB1759, R&D Systems), anti-Sox2 (S1451 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 4-1BB (MAB9371, R&D systems) 1mg/kg was injected on days 0 and 4 through an intravenous route ...
-
bioRxiv - Immunology 2019Quote: ... CCL3/4-APC (93342, R&D Systems), GrB-APC (GB12 ...
-
bioRxiv - Microbiology 2023Quote: ... and Interleukin-4 (R&D Systems, USA) for 7 days as previously described[44] ...
-
bioRxiv - Neuroscience 2024Quote: ... OCT3/4 (1:500, R&D Systems), SMA (1:400 ...
-
bioRxiv - Immunology 2024Quote: ... mouse IL-4 (#DY404, R&D Systems), and mouse IL-9 (#DY409 ...
-
bioRxiv - Immunology 2020Quote: ... the cells were cultured for 5 days in RP10 in the absence or presence of 10 ng/ml human IL-7 (R&D System). Cells were then stimulated for 6 hours with 0.5 μg/ml anti-CD49d clone L25 and 0.5 μg/ml anti-CD28 clone L293 (BD Biosciences) ...
-
bioRxiv - Immunology 2020Quote: ... 5×106 PBMCs were combined with 5×106 irradiated BLCLs from MHC-identical donor MCMs in 5 ml of RPMI-1640 containing 15% FCS (R15) and 10 ng/ml recombinant human IL-7 (R&D Systems). Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Neuroscience 2020Quote: Caspase 3/7 activity was measured using a chromogenic DEVD cleavage assay according to manufacturer’s instructions (R&D Systems, Minneapolis, MN, #K106-100).
-
bioRxiv - Immunology 2020Quote: Intestinal tissues from mice treated with PBS or spore for 7 d and 45 d were lysed with cell lysis buffer (R&D Systems) supplemented with 1% 0.2 mM phenylmethylsulfonyl fluoride (PMSF ...
-
bioRxiv - Developmental Biology 2023Quote: ... gfCDM media was supplemented with 5 nM BMP-4 (R&D Systems, #314-BP-050), followed by 1/2 media change on d9 and d12 ...
-
bioRxiv - Immunology 2022Quote: ... at 37°C in RPMI medium supplemented with 8% human serum and cultured for 7-9 days in the presence of 50 UI/ml of recombinant IL-2 (R&D System).
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.